In April 2024, the Centers for Medicare & Medicaid Services (CMS) released the Contract Year 2025 (CY 2025) Medicare Advantage (MA) and Part D final rule (CMS-4205-F), which included several provisions to simplify plan options for dually eligible individuals and promote greater alignment of Medicare Advantage Prescription Drug (MAPD) dual eligible special needs plans (D-SNPs), and Medicaid managed care organizations (MCOs).